Moderna to Host Conference Call on Phase 1 Interim Analysis for mRNA Flu Vaccine on Friday, December 10
Go back to Moderna to Host Conference Call on Phase 1 Interim Analysis for mRNA Flu Vaccine on Friday, December 10| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 214.30 -10.7 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.00 | 52 Week High | $0.52 | |||
| Open | $224.50 | 52 Week Low | $0.08 | |||
| Day High | $227.46 | P/E | N/A | |||
| Day Low | $212.83 | EPS | $-3.80 | |||
| Volume | 8,703,720 | |||||



